Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats.

Sukoff Rizzo SJ, Pulicicchio C, Malberg JE, Andree TH, Stack GP, Hughes ZA, Schechter LE, Rosenzweig-Lipson S.

Int J Neuropsychopharmacol. 2009 Sep;12(8):1045-53. doi: 10.1017/S1461145709000406. Epub 2009 May 13.

PMID:
19435548
2.

Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.

Cho SJ, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP.

J Med Chem. 2009 Apr 9;52(7):1885-902. doi: 10.1021/jm801354e.

3.

Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.

Hoshaw BA, Hill TI, Crowley JJ, Malberg JE, Khawaja X, Rosenzweig-Lipson S, Schechter LE, Lucki I.

Eur J Pharmacol. 2008 Oct 10;594(1-3):109-16. doi: 10.1016/j.ejphar.2008.07.023. Epub 2008 Jul 17.

4.

VGF, a new player in antidepressant action?

Malberg JE, Monteggia LM.

Sci Signal. 2008 May 6;1(18):pe19. doi: 10.1126/stke.118pe19. Review.

5.

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I.

Brain Res. 2008 May 23;1211:37-43. doi: 10.1016/j.brainres.2008.03.023. Epub 2008 Mar 21.

6.

Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.

Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, Logue SF, Neal SJ, Malberg JE, Beyer CE, Schechter LE, Rosenzweig-Lipson S, Ring RH.

Psychopharmacology (Berl). 2008 May;197(4):601-11. doi: 10.1007/s00213-008-1080-4. Epub 2008 Mar 3.

PMID:
18311561
7.

cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response.

Gur TL, Conti AC, Holden J, Bechtholt AJ, Hill TE, Lucki I, Malberg JE, Blendy JA.

J Neurosci. 2007 Jul 18;27(29):7860-8.

8.

Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects.

Malberg JE, Platt B, Rizzo SJ, Ring RH, Lucki I, Schechter LE, Rosenzweig-Lipson S.

Neuropsychopharmacology. 2007 Nov;32(11):2360-8. Epub 2007 Mar 7.

9.

Ablation of central nervous system progenitor cells in transgenic rats using bacterial nitroreductase system.

Kwak SP, Malberg JE, Howland DS, Cheng KY, Su J, She Y, Fennell M, Ghavami A.

J Neurosci Res. 2007 May 1;85(6):1183-93.

PMID:
17304579
10.

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.

Rosenzweig-Lipson S, Sabb A, Stack G, Mitchell P, Lucki I, Malberg JE, Grauer S, Brennan J, Cryan JF, Sukoff Rizzo SJ, Dunlop J, Barrett JE, Marquis KL.

Psychopharmacology (Berl). 2007 Jun;192(2):159-70. Epub 2007 Feb 13.

PMID:
17297636
11.

Differentiating antidepressants of the future: efficacy and safety.

Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, Rahman Z, Ring RH, Schechter LE.

Pharmacol Ther. 2007 Jan;113(1):134-53. Epub 2006 Sep 27. Review.

PMID:
17010443
12.

Innovative approaches for the development of antidepressant drugs: current and future strategies.

Schechter LE, Ring RH, Beyer CE, Hughes ZA, Khawaja X, Malberg JE, Rosenzweig-Lipson S.

NeuroRx. 2005 Oct;2(4):590-611. Review.

13.

Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications.

Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B, Schechter LE, Rizzo S, Rahman Z, Rosenzweig-Lipson S.

Psychopharmacology (Berl). 2006 Apr;185(2):218-25. Epub 2006 Jan 18.

PMID:
16418825
14.

Antidepressant action: to the nucleus and beyond.

Malberg JE, Blendy JA.

Trends Pharmacol Sci. 2005 Dec;26(12):631-8. Epub 2005 Oct 21. Review.

PMID:
16246434
15.

Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.

Hoshaw BA, Malberg JE, Lucki I.

Brain Res. 2005 Mar 10;1037(1-2):204-8.

PMID:
15777771
16.

Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.

Malberg JE, Schechter LE.

Curr Pharm Des. 2005;11(2):145-55. Review.

PMID:
15638755
17.

Implications of adult hippocampal neurogenesis in antidepressant action.

Malberg JE.

J Psychiatry Neurosci. 2004 May;29(3):196-205. Review.

18.

Neurotoxicity of methamphetamine and methylenedioxymethamphetamine.

Seiden LS, Lew R, Malberg JE.

Neurotox Res. 2001 Jan;3(1):101-16. No abstract available.

PMID:
15111264
19.

Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment.

Malberg JE, Duman RS.

Neuropsychopharmacology. 2003 Sep;28(9):1562-71. Epub 2003 Jul 2.

20.

Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein.

Nakagawa S, Kim JE, Lee R, Malberg JE, Chen J, Steffen C, Zhang YJ, Nestler EJ, Duman RS.

J Neurosci. 2002 May 1;22(9):3673-82.

21.

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.

Malberg JE, Eisch AJ, Nestler EJ, Duman RS.

J Neurosci. 2000 Dec 15;20(24):9104-10.

24.

Supplemental Content

Loading ...
Support Center